Professional Documents
Culture Documents
2016-Satoh-NRF2 Intensifies Host Defense Systems To Prevent
2016-Satoh-NRF2 Intensifies Host Defense Systems To Prevent
Abstract
increased Nrf2 accumulation, whereas Nrf2-deficient mice rarely Urethane-induced lung carcinogenesis experiments
developed such malignant cancers (17). These results indicate that Urethane (ethyl carbamate; 1 g/kg body weight) was intraper-
Nrf2 prevents cancer initiation in the early stages, whereas Nrf2 itoneally administered. At 8 weeks, 16 weeks, and 8 months after
accelerates cancer progression in the advanced stages of urethane- the administration, the mice were euthanized. The lungs were
induced lung carcinogenesis. dissected and the total number of lung surface tumors was
Given the above results from the Nrf2-deficient mice, we counted macroscopically. The diameter of the tumors was mea-
next wanted to address whether constitutive Nrf2 activation sured using an electronic caliper.
affects cancer incidence and malignancy. To this end, we explo-
ited Keap1-knockdown (Keap1-kd) mice that show constitutive Gene expression analysis
Nrf2 accumulation due to a systemic decrease in Keap1 expres- Surface lung tumors were dissected, and surrounding tissues
sion (18). The Keap1-kd mice survive to adulthood and exhibit were carefully removed under a stereoscopic microscope. Tu-
resistance against oxidative and electrophilic insults (19, 20). mors and nontumor tissues in lungs of urethane-administered
Therefore, the Keap1-kd mice serve as an excellent model of mouse were pooled and subjected to a whole-mouse genome
genetic Nrf2 induction. microarray analysis (4 44 k; Agilent Technologies). Expres-
chromatogram of urethane and its positive control urethane- Keap1-kd mice are resistant against urethane-induced
d5 (deuterium-labeled urethane as an internal standard) in tumorigenesis
plasma are shown in Fig. 1C and a SRM chromatogram of To address the question of whether the susceptibility to ure-
VCE and urethane-d5 in urine are shown in Fig. 1D. thane is altered in Keap1-kd mice, we applied the urethane-
The urethane level in the plasma was significantly induced carcinogenesis methodology to the Keap1-kd and
lower in Keap1-kd mice compared with Keap1-wt mice one Keap1-wt mice. We analyzed the effects of urethane treatment
day after the urethane injection (Fig. 1E). Similarly, the under four different experimental conditions: short-term obser-
level of VCE in the urine was also lower in the Keap1-kd vation (8 weeks), mid-term observation (16 weeks), long-term
mice than in the Keap1-wt mice (Fig. 1F). These results observation (8 months), and long-term observation (8 months)
indicate that urethane and its metabolite VCE is efficiently with multiple administrations of urethane.
detoxified and excreted by Keap1-kd mice, presumably by We found that in the short-term observation after a single
virtue of the enhanced activity of the urethane detoxifi- urethane administration, 100.0% (4/4) of the urethane-treated
cation pathway. Keap1-wt mice developed macroscopic (f > 0.5 mm) lung
B. Mid-term observation (16 weeks) after single urethane treatment in Keap1-wt and Keap1-kd mice
Average number of lung surface tumors per
Incidence of lung surface tumors mouse
Tumor size (mm) f > 1.0 f > 1.0
Keap1-wt (n ¼ 4) 4/4 (100.0%) 6.0 3.7
Keap1-kd (n ¼ 6) 1/6 (16.7%)a 0.2 0.4a
C. Long-term observation (8 months) after single urethane treatment in Keap1-wt and Keap1-kd mice
D. Long-term observation (8 month) after four times urethane treatment in Keap1-wt and Keap1-kd mice
Average number of lung surface tumors per
Incidence of lung surface tumors mouse
Tumor size (mm) f > 1.0 f > 3.0 f > 1.0 f > 3.0
Keap1-wt (n ¼ 3)b 3/3 (100.0%) 3/3 (100.0%) 47.0 23.1 9.3 9.1
Keap1-kd (n ¼ 7) 7/7 (100.0%) 4/7 (57.1%) 10.9 4.6a 1.3 1.4c
a
P < 0.01 compared with wild-type mice.
b
Three of Keap1-wt mice dropped out during the experimental term.
c
P < 0.05 compared with wild-type mice.
Keap1-wt mice. Representative tumors taken from the back of A distinct set of 489 genes was exclusively upregulated in
nude mice are shown in Fig. 4A, and the sizes of the tumors the Keap1-kd tumors. Employing IPA analysis, we identified
measured every month are depicted in Fig. 4B. These results 20 downstream genes responsible for the enhanced growth
indicate that the tumor cells derived from Keap1-kd mice are of Keap1-kd tumors and confirmed their differential expres-
more highly proliferative compared with those from the wild- sion patterns between the Keap1-wt and the Keap1-kd tumors
type mice when transplanted into an immunodeficient host (Fig. 5B). Most of the genes encode antioxidant and detoxi-
environment. fication enzymes, which are well-known downstream target
genes of Nrf2 (Supplementary Table S1; refs. 27–31). Of the
Expression profile of cancer-related genes in Keap1-kd tumor 20 genes, Glutathione peroxidase 2 (Gpx2), Catalase (Cat),
cells Ppargc1A, Glutathione-S-transferase a4 (Gsta4), and Glutathione
To explore the mechanisms underlying the enhanced reductase (Gsr) were found to be highly expressed in the Keap1-
growth of Keap1-kd cancer cells in nude mice, we conducted kd cancers in comparison with the Keap1-wt cancers (pink dots
expression microarray analysis and compared the gene expres- in Fig. 5B), and all five of these genes have been reported to
sion profile between Keap1-kd and Keap1-wt tumor cells. For contribute to cancer cell proliferation through eliminating
this purpose, we extracted total RNA from tumors and non- cellular ROS level (32–35). We confirmed this change in gene
cancerous normal tissue from both Keap1-kd and Keap1-wt expression by means of manual quantitative RT-PCR (Fig.
mice 8 months after a single administration of urethane. We 5C). In addition, we noticed an increase in Multidrug resistance
selected genes that were induced more than 2-fold in the protein 3 (Mrp3) expression, which contributes to cellular
tumors relative to normal lung tissue in both genotypes of multidrug resistance (36). These results suggest that the
mice and subjected the expression array data to IPA to identify Keap1-kd cancer cells retain higher level of drug resistance
enriched gene ontology terms. From this analysis, the gene set than do the Keap1-wt cancer cells.
annotated as "cancer-related genes" was identified and sepa- However, it should be noted that the tumors in Keap1-kd
rated into three groups depending on whether they were mice were all small, and that the cancer cells from the
commonly or differentially expressed between Keap1-kd and Keap1-kd mice only proliferated vigorously in the micro-
Keap1-wt tumors (depicted in the Venn diagram; Fig. 5A). A set environment of the nude mouse. Therefore, these results
of 566 genes were found to be commonly upregulated in both demonstrate that, although increased expression of antiox-
the Keap1-kd and Keap1-wt cancer tissues, including genes that idant genes contributes to the enhanced proliferation of
regulate lung development, such as Sox9, Id2, and Foxa2 (data Keap1-kd cancer cells, the proliferation of these tumors is
not shown). These three genes have previously been shown to severely repressed by the anticancer immunity mediated by
participate in lung cancer progression under the regulation of the global increase in Nrf2 activity in Keap1-kd mice (sum-
Nrf2 (17). marized in Fig. 6).
Figure 3.
Long-term urethane-induced lung carcinogenesis. A,
experimental protocol for one-shot urethane
administration. Mouse lungs were examined 8 months
after urethane administration. Representative gross
observations of surface lung tumors in Keap1-wt and
Keap1-kd-mice are depicted. Arrowheads, the surface
tumors. Scale bar, 10 mm. Representative hematoxylin and
eosin–stained sections (bottom). Scale bar, 40 mm. B,
number of surface lung tumors (f > 1 mm) in Keap1-wt (n ¼
7) and Keap1-kd (n ¼ 8) mice. The color of the dots
Discussion
It is widely accepted that Nrf2 attenuates toxicities of many
oncogenic compounds by inducing the expression of a series of
detoxifying and antioxidative stress enzyme genes (1). For
example, urethane treatment induces Nrf2 accumulation, and
the subsequent induction of detoxifying and antioxidative
stress enzymes alleviates the initiation of lung cancers in
wild-type mice (17). In this study, we have demonstrated that
Keap1-kd mice, which express cytoprotective enzymes at a high
level, are significantly resistant to urethane-induced lung car-
cinogenesis, indicating that the cytoprotective enzymes regu-
lated by Nrf2 are crucial for the prevention of urethane-induced
carcinogenesis. Intriguingly, while the number and size of
urethane-induced tumors was significantly decreased in the Figure 4.
Keap1-kd mice, tumor cells derived from the Keap1-kd mice Keap1-kd mice tumors transplanted into nude mice grow larger than that
grew much more vigorously upon transplantation into nude of Keap1-wt mice. A, gross observations of tumors transplanted in
mice than the wild-type mouse–derived cancer cells. These nude mice. Scale bar, 0.5 mm. Representative hematoxylin and
eosin–stained sections (bottom). Scale bar, 20 mm. B, growth curve of
results demonstrate that, while the Keap1-kd mouse–derived
Keap1-wt and Keap1-kd tumors transplanted in nude mice. The data
cancer cells acquire a strong cue for malignant transformation, are presented as the mean SEM. The statistically significant differences
their proliferation ability is severely repressed by the anticancer by Mann–Whitney unpaired U test are depicted ( , P < 0.05; n ¼ 6–8
immunity mediated by the global increase in Nrf2 activity in in each group).
Figure 5.
Identification of the gene expression signature in the Keap1-kd and
Keap1-wt tumors. A, Venn diagram depicting the numbers of genes
induced more than 2-fold in tumors over nontumor lung tissues of
Keap1-wt and Keap1-kd mice. B, heat map comparisons of differentially
expressed genes in the lung tumors of Keap1-wt and Keap1-kd mice.
Pink dots, Nrf2 target genes that contribute to cancer cell malignancy.
C, qRT-PCR analyses of Nrf2 target genes. Statistical significance in
differences by Student t test is indicated ( , P < 0.01).
in experimental carcinogenesis in multiple tissues (42). These Administrative, technical, or material support (i.e., reporting or organiz-
wide-ranging observations suggest that antioxidants may exert ing data, constructing databases): H. Satoh, L. Yu, H. Rokutan, K. Igarashi,
M. Ebina, M. Yamamoto
accelerating effects on cancer progression at the late stages of
Study supervision: M. Yamamoto
carcinogenesis.
Constitutive activation of Nrf2 in Keap1-kd mice produces Acknowledgments
the same positive effect on the proliferation of tumor cells, The authors thank Dr. Yasuhito Arai, Dr. Takanori Hidaka, and Mr. Kohei
but as Nrf2 concomitantly activates anticancer immunity, it Tsuchida for the insightful advice and helpful discussions. The authors also
does not promote unrestricted tumor growth. Thus, our thank the Biomedical Research Core of Tohoku University Graduate School of
results show that the systemic activation of Nrf2 prior to the Medicine for its technical support.
administration of carcinogens prevents urethane-induced
lung carcinogenesis. Grant Support
This work was supported in part by Grants-in-Aid for Scientific Research from
the Ministry of Education, Culture, Sports, Science, and Technology and the
Disclosure of Potential Conflicts of Interest Japan Society for Promotion of Science (T. Moriguchi and M. Yamamoto),
No potential conflicts of interest were disclosed. Scientific Research on Priority Areas (M. Yamamoto) and Specially Promoted
References
1. Itoh K, Mimura J, Yamamoto M. Discovery of the negative regulator of Nrf2, in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer 2007;
Keap1: a historical overview. Antioxid Redox Signal 2010;13:1665–78. 121:1883–91.
2. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small 12. Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, et al. Nrf2 is
Maf heterodimer mediates the induction of phase II detoxifying enzyme essential for the chemopreventive efficacy of oltipraz against urinary
genes through antioxidant response elements. Biochem Biophys Res bladder carcinogenesis. Cancer Res 2004;64:6424–31.
Commun 1997;236:313–22. 13. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, et al. Cancer
3. Anderson N, Paul SH, Henry M. Induction of pulmonary tumors in mice related mutations in NRF2 impair its recognition by Keap1-Cul3 E3
with ethyl carbamate (Urethane). J Natl Cancer Inst 1943;4:309–19. ligase and promote malignancy. Proc Natl Acad Sci U S A 2008;105:
4. Horio Y, Chen A, Rice P, Roth JA, Malkinson AM, Schrump DS. Ki-ras and 13568–73.
p53 mutations are early and late events, respectively, in urethane-induced 14. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, et al.
pulmonary carcinogenesis in A/J mice. Mol Carcinog 1996;17:217–23. Genetic alteration of Keap1 confers constitutive Nrf2 activation and
5. Ghanayem BI, Hoffler U. Investigation of xenobiotics metabolism, geno- resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008;
toxicity, and carcinogenicity using Cyp2e1(-/-) mice. Curr Drug Metab 135:1358–68.
2007;8:728–49. 15. Hayes JD, McMahon M. The double-edged sword of Nrf2: subversion of
6. Kemper RA, Myers SR, Hurst HE. Detoxification of vinyl carbamate redox homeostasis during the evolution of cancer. Mol Cell 2006;21:
epoxide by glutathione: evidence for participation of glutathione S- 732–4.
transferases in metabolism of ethyl carbamate. Toxicol Appl Pharmacol 16. Ma Q.Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol
1995;135:110–8. Toxicol 2013;53:401–26.
7. Su S, Yang X, Omiecinski CJ. Intronic DNA elements regulate Nrf2 chemical 17. Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M. Nrf2 prevents
responsiveness of the human microsomal epoxide hydrolase gene initiation but accelerates progression through the Kras signaling pathway
(EPHX1) through a far upstream alternative promoter. Biochim Biophys during lung carcinogenesis. Cancer Res 2013;73:4158–68.
Acta 2014;1839:493–505. 18. Taguchi K, Maher JM, Suzuki T, Kawatani Y, Motohashi H, Yamamoto M.
8. Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, et al. Gene Genetic analysis of cytoprotective functions supported by graded expres-
expression profiles induced by cancer chemopreventive isothiocyanate sion of Keap1. Mol Cell Biol 2010;30:3016–26.
sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. 19. Reisman SA, Csanaky IL, Aleksunes LM, Klaassen CD. Altered disposition
Cancer Lett 2006;243:170–92. of acetaminophen in Nrf2-null and Keap1-knockdown mice. Toxicol Sci
9. Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, et al. Inhibition of 7,12- 2009;109:31–40.
dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice 20. Wu KC, Liu JJ, Klaassen CD. Nrf2 activation prevents cadmium-induced
by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer acute liver injury. Toxicol Appl Pharmacol 2012;263:14–20.
Res 2006;66:8293–6. 21. Uruno A, Furusawa Y, Yagishita Y, Fukutomi T, Muramatsu H, Negishi T,
10. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, et al. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol Cell
et al. Sensitivity to carcinogenesis is increased and chemoprotective Biol 2013;33:2996–3010.
efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient 22. Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter
mice. Proc Natl Acad Sci U S A 2001;98:3410–5. J, et al. RNAi-mediated silencing of nuclear factor erythroid-2-related factor
11. Osburn WO, Karim B, Dolan PM, Liu G, Yamamoto M, Huso DL, et al. 2 gene expression in non-small cell lung cancer inhibits tumor growth and
Increased colonic inflammatory injury and formation of aberrant crypt foci increases efficacy of chemotherapy. Cancer Res 2008;68:7975–84.
23. Hoffler U, Ghanayem BI. Increased bioaccumulation of urethane in 33. Naiki T, Naiki-Ito A, Asamoto M, Kawai N, Tozawa K, Etani T, et al. GPX2
CYP2E1-/- versus CYP2E1þ/þ mice. Drug Metab Dispos 2005;33: overexpression is involved in cell proliferation and prognosis of castration-
1144–50. resistant prostate cancer. Carcinogenesis 2014;35:1962–7.
24. Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, et al. Nrf2- 34. Salem AF, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Mitochon-
deficiency creates a responsive microenvironment for metastasis to the drial biogenesis in epithelial cancer cells promotes breast cancer tumor
lung. Carcinogenesis 2010;31:1833–43. growth and confers autophagy resistance. Cell Cycle 2012;11:4174–80.
25. Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by mye- 35. Singh S.Cytoprotective and regulatory functions of glutathione S-trans-
loid-derived suppressor cells. Cancer Res 2008;68:2561–3. ferases in cancer cell proliferation and cell death. Cancer Chemother
26. Cardoso CC, Bornstein SR, Hornsby PJ. New methods for investigating Pharmacol 2015;75:1–15.
experimental human adrenal tumorigenesis. Mol Cell Endocrinol 2009; 36. Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, et al.
300:175–9. Oxidative and electrophilic stress induces multidrug resistance-associated
27. Baldelli S, Aquilano K, Ciriolo MR. Punctum on two different tran- protein transporters via the nuclear factor-E2-related factor-2 transcrip-
scription factors regulated by PGC-1alpha: nuclear factor erythroid- tional pathway. Hepatology 2007;46:1597–610.
derived 2-like 2 and nuclear respiratory factor 2. Biochim Biophys Acta 37. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, et al. Altered
2013;1830:4137–46. recognition of antigen is a mechanism of CD8þ T cell tolerance in cancer.
28. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Nat Med 2007;13:828–35.
et al. Nrf2-regulated glutathione recycling independent of biosynthesis is 38. Hiramoto K, Satoh H, Suzuki T, Moriguchi T, Pi J, Shimosegawa T, et al.